OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

Abiomed INC ABIOMED ORD SHS/  US0036541003  /

London Domestic
2022-12-21  6:56:16 PM Chg. - Volume Bid6:00:09 AM Ask6:00:09 AM Market Capitalization Dividend Y. P/E Ratio
380.7907USD - 110
Turnover: 3,807.3628		 -Bid Size: - -Ask Size: - 17.18 bill.USD - 127.01
TeleTrader 2022-11-01 Abiomed skyrockets 50% on J&J's takeover deal
GlobeNewswire 2018-09-24 Data Presented at TCT 2018 Shows Use of Impella and Best Practices Increases Cardiogenic Shock Survi...
GlobeNewswire 2018-09-19 Abiomed to Showcase Expanded FDA Indications and Next Generation Heart Recovery Products at TCT 2018
GlobeNewswire 2018-07-26 Abiomed Announces Q1 FY 2019 Record Revenue of $180 Million, Up 36% Over Prior Year
GlobeNewswire 2018-07-26 Abiomed Announces Q1 FY 2019 Record Revenue of $180 Million, Up 36% Over Prior Year
GlobeNewswire 2018-07-06 Abiomed First Quarter Fiscal 2019 Earnings And Conference Call Notification
GlobeNewswire 2018-05-29 Abiomed to Present at the Jefferies 2018 Healthcare Conference
GlobeNewswire 2018-05-03 Abiomed Announces Q4 FY 2018 Revenue of $174 Million, Up 40%, and Total Year Revenue of $594 Million...
GlobeNewswire 2018-05-03 Abiomed Announces Q4 FY 2018 Revenue of $174 Million, Up 40%, and Total Year Revenue of $594 Million...
GlobeNewswire 2018-04-13 Abiomed Fourth Quarter Fiscal 2018 Earnings and Conference Call Notification
GlobeNewswire 2018-04-05 Abiomed Announces European Approval (CE Marking) for Impella 5.5(TM) and First Patient Treated at Un...
GlobeNewswire 2018-04-04 Abiomed Announces European Approval (CE Marking) for Impella 5.5™ and First Patient Treated at Unive...
GlobeNewswire 2018-04-02 Abiomed Receives FDA Approval for Impella CP® with SmartAssist™ and Optical Sensor
GlobeNewswire 2018-03-30 Abiomed to Appoint New Chief Financial Officer Todd A. Trapp
GlobeNewswire 2018-03-30 Abiomed to Appoint New Chief Financial Officer Todd A. Trapp
GlobeNewswire 2018-03-05 Abiomed Showcases Impella® Technology that Enables Heart Recovery at ACC with 25 Presentations
GlobeNewswire 2018-02-14 Abiomed Receives Approval for Expanded FDA Indication for High Risk Percutaneous Coronary Interventi...
GlobeNewswire 2018-02-13 Abiomed Announces Peripartum and Postpartum Cardiomyopathy Approval and Women’s Initiative for Heart...
GlobeNewswire 2018-02-13 Abiomed Receives Approval for Expanded FDA Indication for Cardiomyopathy with Cardiogenic Shock
GlobeNewswire 2018-02-01 Abiomed Announces Q3 FY 2018 Record Revenue of $154 Million, Up 34% Over Prior Year
GlobeNewswire 2018-02-01 Abiomed Announces Q3 FY 2018 Record Revenue of $154 Million, Up 34% Over Prior Year
GlobeNewswire 2018-01-12 Abiomed Third Quarter Fiscal 2018 Earnings and Conference Call Notification
GlobeNewswire 2018-01-08 Abiomed Announces Preliminary Q3 FY 2018 Revenue of $154 Million, Up 34% Over Prior Year
GlobeNewswire 2018-01-08 Abiomed Announces Preliminary Q3 FY 2018 Revenue of $154 Million, Up 34% Over Prior Year
GlobeNewswire 2017-12-29 Abiomed to Present at the 36th Annual J.P. Morgan Healthcare Conference